Abstract
Kawasaki disease (KD) is an acute systemic vasculitis of childhood. The diagnosis is based on clinical criteria. However, the presentation of KD is incomplete/atypical for approximately 20 % of patients. Kawasaki disease is complicated with coronary artery lesions (CALs) and considered the most common cause of acquired heart disease in children. The medical records of children discharged with KD from a tertiary pediatric hospital in Athens, Greece, during a decade (2001–2010) were retrospectively analyzed. During the study period, KD was diagnosed for 86 children younger than 14 years of age. Complete diagnostic criteria were fulfilled by 64 of the children (74.4 %), whereas 25.6 % were considered incomplete cases. Cardiovascular complications were detected in 48 children (55.8 %) and CALs in 28 children (32.6 %). The prevalence of CALs did not differ significantly between complete and incomplete/atypical KD (42.2 vs 4.5 %; P = 0.001). Logistic regression analysis showed that erythema in the lips and oral cavity was associated with the development of CALs [odds ratio (OR), 3.03; 95 % confidence interval (CI), 1.051–8.783; P = 0.040]. Conversely, children with incomplete/atypical KD (OR, 0.092; 95 % CI, 0.010–0.816; P = 0.032) and previous antibiotic treatment (OR, 0.17; 95 % CI, 0.036–0.875; P = 0.034) were less likely to experience CALs. Children with an incomplete/atypical presentation of KD or before antibiotic treatment may be at lower risk for the development of CALs. Future multicenter studies may help to establish this association better.
Similar content being viewed by others
References
Alexopoulos A, Vekiou A, Lycopoulou L, Tavena A, Lagona E, Kakourou T (2012) Kawasaki disease in Greek children: a retrospective study. J Eur Acad Dermatol Venereol. doi:10.1111/j.1468-3083.2012.04488.x.
Bar-Meir M et al (2011) Kawasaki disease in Israel. Pediatr Infect Dis J 30:589–592
Belay ED et al (2006) Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994–2003. Pediatr Infect Dis J 25:245–249
Burns JC, Glode MP (2004) Kawasaki syndrome. Lancet 364:533–544
Checkley W et al (2009) Short-term weather variability in Chicago and hospitalizations for Kawasaki disease. Epidemiology 20:194–201
Dhillon R et al (1993) Management of Kawasaki disease in the British Isles. Arch Dis Child 69:631–636
Durongpisitkul K et al (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057–1061
Durongpisitkul K et al (2003) Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24:145–148
Egami K et al (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237–240
Ghelani SJ et al (2012) Increased incidence of incomplete Kawasaki disease at a pediatric hospital after publication of the 2004 American Heart Association guidelines. Pediatr Cardiol 33:1097–1103
Holman RC et al (2010) Hospitalizations for Kawasaki syndrome among children in the United States, 1997–2007. Pediatr Infect Dis J 29:483–488
Honkanen VE et al (2003) Clinical relevance of the risk factors for coronary artery inflammation in Kawasaki disease. Pediatr Cardiol 24:122–126
Kato H et al (1979) Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics 63:175–179
Kawasaki T et al (1974) A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics 54:271–276
Kim T et al (2007) Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 166:421–425
Kim SH et al (2009) Clinical characteristics of Kawasaki disease according to age at diagnosis. Indian Pediatr 46:585–590
Kowalczyk M et al (2005) Kawasaki disease in children: 9 years experience. Med Wieku Rozwoj 9:179–193
Leung DY et al (2002) Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. J Pediatr 140:742–746
Manlhiot C et al (2012) Complete and incomplete Kawasaki disease: two sides of the same coin. Eur J Pediatr 171:657–662
McCrindle BW et al (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179
Muta H et al (2006) Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. Acta Paediatr 95:189–193
Nakamura Y et al (2004) Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 46:33–38
Nakamura Y et al (2012) Epidemiologic features of Kawasaki disease in Japan: results of the 2009–2010 nationwide survey. J Epidemiol 22:216–221
Newburger JW, Fulton DR (2004) Kawasaki disease. Curr Opin Pediatr 16:508–514
Newburger JW et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 110:2747–2771
Rigante D et al (2011) Responsiveness to intravenous immunoglobulins and occurrence of coronary artery abnormalities in a single-center cohort of Italian patients with Kawasaki syndrome. Rheumatol Int 30:841–846
Sabharwal T et al (2009) Comparison of factors associated with coronary artery dilation only versus coronary artery aneurysms in patients with Kawasaki disease. Am J Cardiol 104:1743–1747
Sano T et al (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131–137
Schiller B et al (1995) Kawasaki disease in Sweden: incidence and clinical features. Acta Paediatr 84:769–774
Skevaki CL, Charalampaki E, Pinna G, Pararas M, Tsakris A, Kafetzis DA (2011) Kawasaki Disease in a tertiary pediatric referral center in Athens, Greece and review of the literature. In: Amezcua-Guerra LM (ed) Advances in the diagnosis and treatment of vasculitis. ISBN: 978-953-307-786-4. InTech. doi:10.5772/24035. Available from: http://www.intechopen.com/books/advances-in-the-diagnosis-and-treatment-of-vasculitis/kawasaki-disease-in-a-tertiary-pediatric-referral-center-in-athens-greece-and-review-of-the-literatu
Stockheim JA et al (2000) Kawasaki disease in older children and adolescents. J Pediatr 137:250–252
Sudo D et al (2012) Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr 171:651–656
Tremoulet AH et al (2008) Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 153:117–121
Uehara R, Belay ED (2012) Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol 22:79–85
Wallace CA et al (2000) Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 105:E78
Acknowledgments
The authors acknowledge the State Scholarship Foundation of Greece for funding this research.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giannouli, G., Tzoumaka-Bakoula, C., Kopsidas, I. et al. Epidemiology and Risk Factors for Coronary Artery Abnormalities in Children With Complete and Incomplete Kawasaki Disease During a 10-Year Period. Pediatr Cardiol 34, 1476–1481 (2013). https://doi.org/10.1007/s00246-013-0673-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-013-0673-9